UNSPSC 51183602: Glucagon

This classification denotes a peptide hormone, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 76LA80IG2G. European Medicines Agency schedules Glucagon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02347MIG. Glucagon generally arises in the molecular formula C153H225N43O49S. The term GLUCAGON is a European Pharmacopoeia designation. GLUCAGON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51183602 Glucagon, a Commodity code, covers the procurement of glucagon pharmaceutical products by state and local health agencies, correctional facilities, emergency medical services, and school districts. Glucagon is a hormone medication used to treat severe hypoglycemia (dangerously low blood sugar) in diabetic patients and is stocked in emergency response kits, first-aid supplies, and medical facilities operated by or contracted to public bodies. State and local governments procure glucagon in multiple formulations — including injectable vials, pre-filled syringes, and nasal spray delivery systems — for use in public health departments, prison infirmaries, ambulance services, and schools with student populations requiring diabetes management. Purchasing is driven by regulatory requirements, emergency preparedness standards, and the need to maintain consistent stock rotation in high-turnover settings.

The source provided contains no recent state and local contract opportunities tagged to this code, preventing characterization of the active issuing-body mix, geographic spread, or representative recent solicitations.